Stella M Valenzuela

Prof. Stella M Valenzuela

School of Life Sciences, University of Technology Sydney, Sydney, New South Wales 2007, Australia
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 1997 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MBMichelle R. Bootcov
Michelle R. Bootcov
ABAsne R. Bauskin
Asne R. Bauskin
Stella M ValenzuelaStella M Valenzuela
Stella M Valenzuela
AMAnthony G. Moore
Anthony G. Moore
MBMohinder Bansal
Mohinder Bansal
SBSamuel N. Breit
Samuel N. Breit
Macrophages play a key role in both normal and pathological processes involving immune and inflammatory responses, to a large extent through their capacity to secrete a wide range of biologically active molecules. To identify some of these as yet not characterized molecules, we have used a subtraction cloning approach designed to identify genes expressed in association with macrophage activation. One of these genes, designated macrophage inhibitory cytokine 1 (MIC-1), encodes a protein that bears the structural characteristics of a transforming growth factor β (TGF-β) superfamily cytokine. Although it belongs to this superfamily, it has no strong homology to existing families, indicating that it is a divergent member that may represent the first of a new family within this grouping. Expression of MIC-1 mRNA in monocytoid cells is up-regulated by a variety of stimuli associated with activation, including interleukin 1β, tumor necrosis factor α (TNF-α), interleukin 2, and macrophage colony-stimulating factor but not interferon γ, or lipopolysaccharide (LPS). Its expression is also increased by TGF-β. Expression of MIC-1 in CHO cells results in the proteolytic cleavage of the propeptide and secretion of a cysteine-rich dimeric protein ofMr25 kDa. Purified recombinant MIC-1 is able to inhibit lipopolysaccharide -induced macrophage TNF-α production, suggesting that MIC-1 acts in macrophages as an autocrine regulatory molecule. Its production in response to secreted proinflammatory cytokines and TGF-β may serve to limit the later phases of macrophage activation.

1 February 2006 in Trends in Biotechnology
Verified
Journal Article
Closed access
DPDakrong Pissuwan
Dakrong Pissuwan
Stella M ValenzuelaStella M Valenzuela
Stella M Valenzuela
MCMichael Cortie
Michael Cortie

1 April 2010 in Trends in Biotechnology
Verified
Journal Article
Closed access
DPDakrong Pissuwan
Dakrong Pissuwan
CCColin H. Cortie
Colin H. Cortie
Stella M ValenzuelaStella M Valenzuela
Stella M Valenzuela
MCMichael Cortie
Michael Cortie

1 November 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SHStephen J. Harrop
Stephen J. Harrop
MDMatthew Z. DeMaere
Matthew Z. DeMaere
Walter FairlieWalter Fairlie
Walter Fairlie
TRTamara Reztsova
Tamara Reztsova
Stella M ValenzuelaStella M Valenzuela
Stella M Valenzuela
PCPaul M.G. Curmi
Paul M.G. Curmi
CLIC1 (NCC27) is a member of the highly conserved class of chloride ion channels that exists in both soluble and integral membrane forms. Purified CLIC1 can integrate into synthetic lipid bilayers forming a chloride channel with similar properties to those observed in vivo. The structure of the soluble form of CLIC1 has been determined at 1.4-Å resolution. The protein is monomeric and structurally homologous to the glutathioneS-transferase superfamily, and it has a redox-active site resembling glutaredoxin. The structure of the complex of CLIC1 with glutathione shows that glutathione occupies the redox-active site, which is adjacent to an open, elongated slot lined by basic residues. Integration of CLIC1 into the membrane is likely to require a major structural rearrangement, probably of the N-domain (residues 1–90), with the putative transmembrane helix arising from residues in the vicinity of the redox-active site. The structure indicates that CLIC1 is likely to be controlled by redox-dependent processes.

18 January 2010 in FEBS Letters
Verified
Journal Article
Closed access
DLDene R. Littler
Dene R. Littler
SHStephen J. Harrop
Stephen J. Harrop
SGSophia Goodchild
Sophia Goodchild
JPJuanita M. Phang
Juanita M. Phang
AMAndrew V. Mynott
Andrew V. Mynott
PCPaul M.G. Curmi
Paul M.G. Curmi

1 May 1997 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Stella M ValenzuelaStella M Valenzuela
Stella M Valenzuela
DMDonald K. Martin
Donald K. Martin
SPSuzanne B. Por
Suzanne B. Por
JRJoan M. Robbins
Joan M. Robbins
KWKristina Warton
Kristina Warton
SBSamuel N. Breit
Samuel N. Breit
Ion channels are known to be present on the plasma membrane of virtually all cells and have been found on the membranes of various intracellular organelles. However, until recently they were believed not to occur at the nuclear membrane. In this study we describe the molecular cloning and characterization of a nuclear ion channel protein, designated nuclear chloride channel-27 (NCC27), from the human myelomonocytic cell line, U937. NCC27 is a novel chloride ion channel protein that was found to localize principally to the cell nucleus. Its only known homologue is a bovine chloride ion channel protein (p64) believed to localize to internal organelles. NCC27 therefore represents the first human member of a new class of organellar chloride ion channel proteins.